anlotinib,sintilimab
Not Tagged
['sintilimab', 'anlotinib']
study design here shows randomization to first-line sintilimab + anlotinib or chemo (with sintilimab at progression). some concerns about randomization to chemotherapy without immunotherapy in a modern day study. #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him